BRIEF-Merck research chief says dealmaking to continue at same or faster pace - News

Runway Angels
The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.
Smartphone Guide
Here's a need-to-know guide to nine devices, based on features, price, network and platform.
Wines for the Holidays
Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES

How Well Do You Know Your Bird?
Let's talk turkey. Test your turkey knowledge and perhaps pick up a bit of trivia to trot out at your holiday meal.
A Healthier & Wealthier You
Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.
The Billionaire BFF's
Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?

SPECIAL REPORTS

Winterizing Your Portfolio
If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.
Investor's Guide to Real Estate
Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.
Alternative Investing
Stocks and bonds? Sure. But it's a big world out there for investors.

CNBC ON DIGG

BRIEF-Merck research chief says dealmaking to continue at same or faster pace

By: AFX | 04 Nov 2009 | 08:53 AM ET

Text Size

Nov 4 (Reuters) - Merck & Co Inc: * & co research chief says company will seek new drug-licensing deals and acquisitions at same or faster pace than before Schering-Plough merger * & co research chief says company, having merged with Schering-Plough, has "best pipeline in pharmaceuticals industry by far" * Research chief says newly combined company has more than 15 drugs in late-stage trials * Research chief says merck's cardiovascular business stands out "loud and clear" as industry's best heart-drug franchise * Research chief says company will be strong competitor in women's health, bolstered by Schering-Plough brands * Research chief says holding off decisions on layoffs in research and development operations until assessing talent, research projects ((New York Equities Desk; tel: +1 646 223 6000)) (For more news about Merck & Co Inc click here:) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

Tools: